Atika Capital Management LLC Invitae Corp Call Options Transaction History

Atika Capital Management LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 11, 2022	SELL	$14.7 - $28.67 $22,050 - $43,005	-1,500 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$33.06 - $56.93 $4.91 Million - $8.45 Million	-148,500 Reduced 99.0%	1,500 $5.73 Million
Q1 2020 May 14, 2020	BUY	$7.64 - $27.5 $1.15 Million - $4.13 Million	150,000 New	150,000 $2.05 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Atika Capital Management LLC with notifications on news.